These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 2462603)

  • 1. Immunochemical specificity of human antibodies to lipopolysaccharide from the J5 rough mutant of Escherichia coli O111:B4.
    Schwartzer TA; Alcid DV; Numsuwan V; Gocke DJ
    J Infect Dis; 1989 Jan; 159(1):35-42. PubMed ID: 2462603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-reactivity of rabbit antibodies to lipopolysaccharides of Escherichia coli J5 and other gram-negative bacteria.
    Siber GR; Kania SA; Warren HS
    J Infect Dis; 1985 Nov; 152(5):954-64. PubMed ID: 2413146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-reactivity of monoclonal antibodies to Escherichia coli J5 with heterologous gram-negative bacteria and extracted lipopolysaccharides.
    Aydintug MK; Inzana TJ; Letonja T; Davis WC; Corbeil LB
    J Infect Dis; 1989 Nov; 160(5):846-57. PubMed ID: 2681436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies to lipopolysaccharides after immunization of humans with the rough mutant Escherichia coli J5.
    Baumgartner JD; Heumann D; Calandra T; Glauser MP
    J Infect Dis; 1991 Apr; 163(4):769-72. PubMed ID: 2010630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effects of polyclonal sera and of monoclonal antibodies active to Salmonella minnesota Re595 lipopolysaccharide during experimental endotoxemia.
    Nys M; Cloes JM; Demonty J; Joassin L
    J Infect Dis; 1990 Nov; 162(5):1087-95. PubMed ID: 1700024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Demonstration of cross-reactive antibodies to smooth gram-negative bacteria in antiserum to Escherichia coli J5.
    Baumgartner JD; O'Brien TX; Kirkland TN; Glauser MP; Ziegler EJ
    J Infect Dis; 1987 Jul; 156(1):136-43. PubMed ID: 2439613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serological relationships between Escherichia coli and Salmonella smooth- and rough-mutant lipopolysaccharides as revealed by enzyme-linked immunosorbent assay for human immunoglobulin G antiendotoxin antibodies.
    Barclay GR; Scott BB
    Infect Immun; 1987 Nov; 55(11):2706-14. PubMed ID: 3312008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endotoxin neutralization with rabbit antisera to Escherichia coli J5 and other gram-negative bacteria.
    Warren HS; Novitsky TJ; Bucklin A; Kania SA; Siber GR
    Infect Immun; 1987 Jul; 55(7):1668-73. PubMed ID: 3298063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement activating and opsonic capacity of monoclonal antibodies raised against Escherichia coli O111 and its rough mutant J5.
    Vreede RW; Leuvenink J; Bouter AS; Brouwer EC; Marcelis JH; Verhoef J
    Eur J Clin Microbiol; 1986 Apr; 5(2):141-7. PubMed ID: 3522225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Failure of monoclonal antibodies to core glycolipid to bind intact smooth strains of Escherichia coli.
    Gigliotti F; Shenep JL
    J Infect Dis; 1985 Jun; 151(6):1005-11. PubMed ID: 2582064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigenic homology of endotoxin with a coliform mastitis vaccine strain, Escherichia coli O111:B4 (J5).
    Tyler JW; Spears H; Nelson R
    J Dairy Sci; 1992 Jul; 75(7):1821-5. PubMed ID: 1500577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A noncovalent complex vaccine prepared with detoxified Escherichia coli J5 (Rc chemotype) lipopolysaccharide and Neisseria meningitidis Group B outer membrane protein produces protective antibodies against gram-negative bacteremia.
    Bhattacharjee AK; Opal SM; Taylor R; Naso R; Semenuk M; Zollinger WD; Moran EE; Young L; Hammack C; Sadoff JC; Cross AS
    J Infect Dis; 1996 May; 173(5):1157-63. PubMed ID: 8627067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody specific for Escherichia coli J5 cross-reacts to various degrees with an Escherichia coli clinical isolate grown for different lengths of time.
    McCallus DE; Norcross NL
    Infect Immun; 1987 May; 55(5):1042-6. PubMed ID: 3552983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies to core lipopolysaccharide determinants: absence of cross-reactivity with heterologous lipopolysaccharides.
    Heumann D; Baumgartner JD; Jacot-Guillarmod H; Glauser MP
    J Infect Dis; 1991 Apr; 163(4):762-8. PubMed ID: 1707084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-reactivity of monoclonal antibodies against lipopolysaccharides of gram-negative bacteria.
    de Jongh-Leuvenink J; Bouter AS; Marcelis JH; Schellekens J; Verhoef J
    Eur J Clin Microbiol; 1986 Apr; 5(2):148-51. PubMed ID: 2424754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Affinity-purified Escherichia coli J5 lipopolysaccharide-specific IgG protects neutropenic rats against gram-negative bacterial sepsis.
    Bhattacharjee AK; Opal SM; Palardy JE; Drabick JJ; Collins H; Taylor R; Cotton A; Cross AS
    J Infect Dis; 1994 Sep; 170(3):622-9. PubMed ID: 8077720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reactivity of monoclonal antibody E5 with endotoxin. I. Binding to lipid A and rough lipopolysaccharides.
    Wood DM; Parent JB; Gazzano-Santoro H; Lim E; Pruyne PT; Watkins JM; Spoor ES; Reardan DT; Trown PW; Conlon PJ
    Circ Shock; 1992 Sep; 38(1):55-62. PubMed ID: 1394865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzyme immunoassay for the quantitation of immunoglobulin M class antibodies to Salmonella minnesota R595 and Escherichia coli J5 lipopolysaccharides.
    Vanesian MA; Fung G; Bagdasarian A
    Diagn Microbiol Infect Dis; 1987 Jan; 6(1):11-25. PubMed ID: 3542358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of anti-core glycolipid monoclonal antibodies with chemically defined lipopolysaccharides.
    de Jongh-Leuvenink J; Schellekens J; Verhoef J
    Infect Immun; 1990 Feb; 58(2):421-6. PubMed ID: 2404871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigenic and immunogenic differences in lipopolysaccharides of Escherichia coli J5 vaccine strains of different origins.
    Appelmelk BJ; Maaskant JJ; Verweij-van Vught AM; van der Meer NM; Thijs BG; MacLaren DM
    J Gen Microbiol; 1993 Nov; 139(11):2641-7. PubMed ID: 7506295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.